AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LEVETIRACETAM 500.000 Mg ;
12 registrations across 1 African market— 12 active
Markets with LEVETIRACETAM 500.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| KEPRADIL 500mg Film Coated Tablets | 🇪🇬Egypt | Hikma pharma | active | — |
| Tiratam XR 500mg Extended Release Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Tiratam XR 500mg Extended Release Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| Tiratam 500 mg F.C.T. Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| TIRALEPSY XR 500mg Extended Release Film Coated Tablets | 🇪🇬Egypt | PROTECH PHARMACEUTICAL COMPANY | active | — |
| TIRALEPSY 500 mg Film Coated Tablets | 🇪🇬Egypt | PROTECH PHARMACEUTICAL COMPANY | active | — |
| Vitiracetam 500 mg Film Coated Tablets | 🇪🇬Egypt | SAJA Pharmaceuticals Egypt - SAJA | active | — |
| Olmedersa Film Coated Tablets | 🇪🇬Egypt | Origin International Pharma | active | — |
| Vitiracetam 500 mg Film Coated Tablets | 🇪🇬Egypt | SAJA Pharmaceuticals Egypt - SAJA | active | — |
| Tiratam 500 mg F.C.T. Film Coated Tablets | 🇪🇬Egypt | al andalous for pharmaceutical industries | active | — |
| TIRALEPSY XR 500mg Extended Release Film Coated Tablets | 🇪🇬Egypt | PROTECH PHARMACEUTICAL COMPANY | active | — |
| TIRALEPSY 500 mg Film Coated Tablets | 🇪🇬Egypt | PROTECH PHARMACEUTICAL COMPANY | active | — |
LEVETIRACETAM 500.000 Mg ; in Africa — Regulatory Overview
LEVETIRACETAM 500.000 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.